Delray Beach, FL, Aug. 14, 2025 (GLOBE NEWSWIRE) — Advanced patient monitoring solutions see rising adoption amid aging populations, chronic disease prevalence, and healthcare infrastructure expansion
The global pulse oximeters market, valued at US$3.59 billion in 2024, stood at US$3.92 billion in 2025 and is projected to advance at a resilient CAGR of 8.7% from 2025 to 2032, culminating in a forecasted valuation of US$7.03 billion by the end of the period. This growth trajectory reflects increasing demand for non-invasive oxygen monitoring devices across hospital, homecare, and ambulatory care settings.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=68168578
What is driving the market?
An escalating global burden of respiratory diseases such as COPD, asthma, and pneumonia, coupled with the rising incidence of congenital heart disease (CHD) in children, is significantly boosting demand. The expansion of surgical procedures, increased hospital admissions, and a growing geriatric population further reinforce the market’s upward momentum. Technological advancements in portable, wearable, and connected pulse oximeters are enabling real-time patient monitoring, while emerging markets present untapped growth potential through healthcare modernization and manufacturing expansion.
Why does this matter now?
In a post-pandemic landscape, healthcare systems worldwide are prioritizing early detection, remote monitoring, and cost-effective care delivery. Pulse oximeters—critical for monitoring blood oxygen saturation—are becoming standard across care settings, from high-acuity hospitals to home-based patient management. Strategic investments today could secure competitive advantage in a market primed for sustained growth.
Market Dynamics at a Glance
- Drivers: Rising prevalence of respiratory conditions, growing geriatric population, technological breakthroughs.
- Restraints: Stringent regulatory requirements and accuracy concerns for over-the-counter (OTC) devices.
- Opportunities: Expansion of manufacturing and distribution in emerging economies, adoption in decentralized clinical trials, integration with telehealth platforms.
- Challenges: Inadequate healthcare infrastructure in rural and …